Issue of Ordinary Shares under the Scrip Dividend Scheme of 214 shares
Helios Underwriting Plc
16 July 2026
16 July 2026
Helios Underwriting plc
("Helios" or the "Company")
Director/PDMR Shareholding
Helios, the only publicly traded company offering instant access to a diverse portfolio of syndicates at Lloyd's of London, the world's largest insurance market, was informed on 15 July 2026 that Mr Nigel Hanbury, Non-Executive Deputy Chairman and Director of the Company and persons closely associated with Mr Hanbury, have been issued with a total of 351,594 ordinary shares of 10p each ("Ordinary Shares") at the scrip dividend reference price of 214.1p per share. Mr Hanbury is now interested in 7,879,373 Ordinary Shares, representing 11.24% of the Company's voting rights.
The notification below, which has been made in accordance with the requirement of the UK Market Abuse Regulation, provides further details.
For further information, please contact:
Helios Underwriting plc
Louis Tucker - Chief Executive Officer +44 (0)20 3965 6441
Adhiraj Maitra - Director of Finance and Operations +44 (0)20 3743 2114
Peel Hunt (Nomad, Broker and Financial Adviser)
Dan Webster / Andrew Buchanan / Martin Frowde +44 (0)20 7418 8900
Singer Capital Markets (Joint Broker)
Charles Leigh-Pemberton / Russell Cook / James Todd +44 (0)20 7496 3000
FTI Consulting
Ed Berry +44 (0)7703 330 199
Christian Harte +44 (0)7974 288 763
About Helios
Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market. The portfolio provides a broad spread of business primarily participating in the US and other international wholesale and reinsurance markets. For further information please visit www.huwplc.com.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||||||||||||||||||||||
|
a) |
Name |
Nigel Hanbury (Director) Clementine Hanbury (PCA) Elizabeth Hanbury (PCA) George Hanbury (PCA) |
||||||||||||||||||||||||||||
|
2 |
Reason for the notification |
|||||||||||||||||||||||||||||
|
|
|
Director PCA |
||||||||||||||||||||||||||||
|
b) |
Initial notification/Amendment |
Initial Notification |
||||||||||||||||||||||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||||||||||||||||||||
|
a) |
Name |
Helios Underwriting Plc |
||||||||||||||||||||||||||||
|
b) |
LEI |
213800FX86DJW5TCM864 |
||||||||||||||||||||||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||||||||||||||||||
|
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary Shares of 10 pence each ISIN - GB00B23XLS45 |
||||||||||||||||||||||||||||
|
b) |
Nature of the transaction |
Issue of Ordinary Shares under the Scrip Dividend Scheme |
||||||||||||||||||||||||||||
|
c) |
Price(s) and volume(s)
|
|
||||||||||||||||||||||||||||
|
d) |
Aggregated information |
|
||||||||||||||||||||||||||||
|
e) |
Date of the transaction |
10 July 2026 |
||||||||||||||||||||||||||||
|
f) |
Place of the transaction |
London Stock Exchange, AIM |
||||||||||||||||||||||||||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.